Concord Biotech Ltd Q2 FY2024-2025 Results: Summary
Revenue | ₹320.21Cr |
Net Profits | ₹95.74Cr |
Net Profit Margins | 29.90% |
Highlights
Revenue:
Concord Biotech Ltd’s revenue jumped 18.39% since last year same period to ₹320.21Cr in the Q2 2024-2025. On a quarterly growth basis, Concord Biotech Ltd has generated 40.78% jump in its revenue since last 3-months.
Net Profits:
Concord Biotech Ltd’s net profit jumped 18.17% since last year same period to ₹95.74Cr in the Q2 2024-2025. On a quarterly growth basis, Concord Biotech Ltd has generated 60.66% jump in its net profits since last 3-months.
Net Profit Margins:
Concord Biotech Ltd’s net profit margin fell -0.19% since last year same period to 29.90% in the Q2 2024-2025. On a quarterly growth basis, Concord Biotech Ltd has generated 14.13% jump in its net profit margins since last 3-months.
